Varian, Inc.
Palo Alto, CA 94304
First Cancer Patient Treated with Varian ProBeam Compact Proton Therapy System at Treatment Center in Florida
PALO ALTO, Calif., Nov. 18, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the South Florida Proton Therapy Institute (SFPTI), a Proton International facility, on the campus of Delray Medical Center, has treated its first patient utilizing the Varian ProBeam® Compact single-room proton therapy system. Proton therapy can be used to treat many types of tumors including in the brain,...
Read More »
Varian ProBeam 360 Proton Therapy System Selected by Penn Medicine for Use in Second Treatment Center
Palo Alto, Calif., Oct. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has been selected by Penn Medicine to install a Varian ProBeam® 360° proton therapy system in a single-room configuration at Lancaster General Health Ann B. Barshinger Cancer Institute in south central Pennsylvania. In addition to the equipment, Varian will also provide its ARIA® information management...
Read More »
Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center Achieve Significant Milestone in Research of FLASH Therapy
PALO ALTO, Calif., Oct. 14, 2019 /PRNewswire/ -- Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant milestone in the path towards clinical trials of FLASH therapy*. The combined research team utilized a Varian ProBeam® proton therapy gantry treatment room...
Read More »
New Proton Therapy System Offers Clinical Capabilities with up to 30% Small Footprint
ProBeam 360° system allows cancer centers to tailor the system to meet their clinical, research, and capacity needs. Treatment room options include 360-degree rotating gantries, and fixed beam rooms. Provide clinicians a viable path to potential next-generation treatments such as FLASH therapy.
Read More »
New Ethos Therapy Provides Fast Imaging and Treatment Delivery
Offers the use of multimodality images (MR, PET, CT) and daily iterative CBCT images at the console. Ability to alter the treatment plan based on tumor and anatomical changes. Enable users to visualize the changes in patient's anatomy and adapts the therapy accordingly to help provide treatments to patients.
Read More »
Varian-Equipped New York Proton Therapy Center Treats First Patients
PALO ALTO, Calif., Sept. 10, 2019 /PRNewswire/ -- The New York Proton Center (NYPC) has treated its first proton therapy cancer patients. Equipped with the Varian ProBeam® proton therapy system, NYPC is New York State's first proton therapy facility and is a collaboration between Memorial Sloan Kettering Cancer Center, Montefiore Health System, and Mount Sinai Health System. NYPC is expected to...
Read More »
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at Sylvester Comprehensive Cancer Center
Palo Alto, Calif., Aug. 28, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has completed the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine -- part of the University of Miami Health System. The cyclotron is a particle accelerator and a significant piece of...
Read More »Three Radiotherapy Centers in Serbia Standardize on Varian Solution for Cancer Treatment Planning
Palo Alto, Calif., July 29, 2019 /PRNewswire/ -- Following a public competitive review process, Varian (NYSE: VAR) was selected to supply its Eclipse™ treatment planning software and ARIA® oncology information system to three radiotherapy centers in Serbia. The Varian solution will be replacing competitive solutions at the Institute for Oncology and Radiology of Serbia – Belgrade (IORS),...
Read More »
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Palo Alto, Calif., July 9, 2019 /PRNewswire/ -- Varian (NYSE: VAR) celebrated the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand on June 20, 2019. HRH Princess Maha Chakri Sirindhorn presided over the rigging ceremony. The cyclotron is a core piece of equipment of the ProBeam proton...
Read More »
Varian Provides TrueBeam System for IAEA Dosimetry Laboratory in Austria
PALO ALTO, Calif., July 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) is working in partnership with the International Atomic Energy Agency (IAEA) to improve cancer treatment by helping hospitals around the world deliver more precise radiotherapy doses. Through the partnership, Varian made available a TrueBeam™ system to the IAEA's Dosimetry Laboratory in Seibersdorf, Austria, which will enhance...
Read More »Varian Establishes Direct Operation in Kenya
PALO ALTO, California and NAIROBI, Kenya, Nov. 26, 2019 /PRNewswire/ -- At a grand opening ceremony attended by local dignitaries (H.E. Governor Prof. Anyan'g Nyong'o – Governor of Kisumu County, Vice Chairman – CoG Health Committee; Hon. Dr. Swarup Mishra Kiprop Arap Chelulei – MP – Kesses, Group Chairman, Founder Mediheal Hospitals, Vice Chairman - Parliament Health Committee;...
Read More »
First Cancer Patient Treated with Varian ProBeam Compact Proton Therapy System at Treatment Center in Florida
PALO ALTO, Calif., Nov. 18, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the South Florida Proton Therapy Institute (SFPTI), a Proton International facility, on the campus of Delray Medical Center, has treated its first patient utilizing the Varian ProBeam® Compact single-room proton therapy system. Proton therapy can be used to treat many types of tumors including in the brain,...
Read More »Varian Named One of America's Most Just Companies in 2019 by Forbes and JUST Capital
Palo Alto, Calif., Nov. 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced for the third year in a row, it was named one of America's Most JUST Companies in 2019, according to the JUST Capital and Forbes magazine JUST 100 List. Varian was ranked number three in the Healthcare Equipment and Services Industry and number 39 on this year's overall list for outperforming its peers in...
Read More »Varian Selected by Michigan Oncology Quality Consortium to Support Transition to Value-Based Ca
PALO ALTO, Calif., Nov. 6, 2019 /PRNewswire/ -- In an effort to elevate the patient voice in cancer care, Varian (NYSE: VAR) announced it has been selected as the vendor of choice by the Michigan Oncology Quality Consortium (MOQC) to support its efforts to develop patient-centered quality measures for cancer care. This year, there were an estimated 58,000 new cancer cases in the state of...
Read More »Varian Names Anshul Maheshwari Vice President Investor Relations
Palo Alto, Calif., Oct. 29, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced Anshul Maheshwari, vice president and treasurer will take on an expanded role of Investor Relations effective December 1, 2019. All future investor inquiries should be directed to Mr. Maheshwari. Prior to joining Varian in July 2018, Mr. Maheshwari was the assistant treasurer of Bechtel Corporation, where he had...
Read More »
Varian ProBeam 360 Proton Therapy System Selected by Penn Medicine for Use in Second Treatment Center
Palo Alto, Calif., Oct. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has been selected by Penn Medicine to install a Varian ProBeam® 360° proton therapy system in a single-room configuration at Lancaster General Health Ann B. Barshinger Cancer Institute in south central Pennsylvania. In addition to the equipment, Varian will also provide its ARIA® information management...
Read More »
Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center Achieve Significant Milestone in Research of FLASH Therapy
PALO ALTO, Calif., Oct. 14, 2019 /PRNewswire/ -- Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center announced the achievement of a significant milestone in the path towards clinical trials of FLASH therapy*. The combined research team utilized a Varian ProBeam® proton therapy gantry treatment room...
Read More »Varian U.S. Tariff Exclusion Request Granted for Radiotherapy System Components
PALO ALTO, Calif., Sept. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators manufactured in the U.S from Section 301 tariffs. The exemption became effective on September 20, 2019. We are thankful for the USTR and U.S. government's continued recognition of the...
Read More »Varian Ranked Highest in Survey of US Radiation Oncology Professionals
PALO ALTO, Calif., Sept. 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) has been recognized again as a leader in the annual IMV ServiceTrak™ Radiation Oncology Systems report, ranking first in eight of the tracked categories. Additionally, Varian's Net Promotor Score improved from 71 in 2018 to 78 in 2019, and again was the highest among industry competitors. Net Promotor Scores represents the...
Read More »
New Proton Therapy System Offers Clinical Capabilities with up to 30% Small Footprint
ProBeam 360° system allows cancer centers to tailor the system to meet their clinical, research, and capacity needs. Treatment room options include 360-degree rotating gantries, and fixed beam rooms. Provide clinicians a viable path to potential next-generation treatments such as FLASH therapy.
Read More »